Contrary to the results from previous studies, a new study has found that epilepsy drug oxcarbazepine may not be effective enough in preventing migraines.
The study was conducted over 170 men and women at clinics across the United States. Half of the group received a daily dose of oxcarbazepine while the other half took placebo.
The findings revealed that both groups did not experience any change in the number of migraine attacks from the beginning to the end of the study.
Dr Stephen D. Silberstein, study author with Thomas Jefferson University in Philadelphia, and Fellow of the American Academy of Neurology said that the results do not support preliminary data suggesting oxcarbazepine was effective in preventing migraine
"While several epilepsy drugs have been used for decades to prevent migraine, oxcarbazepine did not prevent migraine in this study despite it being shown to be safe and well-tolerated," he said.
The findings appear in the medical journal of the American Academy of Neurology.